Late-onset myasthenia not on the increase: a nationwide register study in Denmark, 1996-2009

Autor: David Gaist, P. E. H. Jensen, Emil Greve Pedersen, Klaus Hansen, Jesper Hallas

Publikováno v: Pedersen, E G, Hallas, J, Hansen, K, Jensen, P E H & Gaist, D 2013, ' Late-onset myasthenia not on the increase : a nationwide register study in Denmark, 1996-2009 ', European Journal of Neurology, vol. 20, no. 2, pp. 309-314 . https://doi.org/10.1111/j.1468-1331.2012.03850.x

Background An increase in late-onset myasthenia gravis (MG) has been reported. There are few large population-based studies over longer periods of time reflecting recent developments in MG incidence. Methods We identified a nationwide cohort of patie

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::74e877a7bacabd6ab60971239fcd9ada
https://doi.org/10.1111/j.1468-1331.2012.03850.x

Risk of non-melanoma skin cancer in myasthenia patients treated with azathioprine

Autor: P. E. H. Jensen, Klaus Hansen, Søren Friis, Jesper Hallas, David Gaist, Emil Greve Pedersen, Anton Pottegård

Publikováno v: Pedersen, E G, Pottegård, A, Hallas, J, Friis, S, Hansen, K, Jensen, P E H & Gaist, D 2014, ' Risk of non-melanoma skin cancer in myasthenia patients treated with azathioprine ', European Journal of Neurology, vol. 21, no. 3, pp. 454-458 . https://doi.org/10.1111/ene.12329

Background and purpose: The association between use of azathioprine and risk of non-melanoma skin cancer (NMSC) in patients with myasthenia was evaluated in a nationwide setting. Treatment of autoimmune myasthenia frequently involves long-term exposu

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::28bdd3984034eb506d1caa13a3318f8b
https://pubmed.ncbi.nlm.nih.gov/24330255

Identification of new sensitive biomarkers for the in vivo response to interferon-beta treatment in multiple sclerosis using DNA-array evaluation

Autor: F, Sellebjerg, M, Krakauer, D, Hesse, L P, Ryder, I, Alsing, P E H, Jensen, N, Koch-Henriksen, A, Svejgaard, P, Soelberg Sørensen

Publikováno v: European journal of neurology. 16(12)

Neutralizing antibodies (NAbs) occur in a proportion of multiple sclerosis (MS) patients treated with interferon (IFN)-beta. NAbs impair the effect of treatment. The biological effect of IFN-beta can be measured as the induction of the myxovirus resi

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::a31293d63b5c5e82aac8285229d8b1dc
https://pubmed.ncbi.nlm.nih.gov/19558503

Native and transformed alpha2-macroglobulin in plasma from patients with multiple sclerosis

Autor: M, Gunnarsson, P, Sundström, T, Stigbrand, P E H, Jensen

Publikováno v: Acta neurologica Scandinavica. 108(1)

Multiple sclerosis (MS) is an inflammatory demyelinating disease with unknown etiology. Various proteinases have been observed in increased levels in the central nervous system of patients with MS, which may contribute to the release of immunogenic m

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::1161005e0daf20e22b50f89fdca86135
https://pubmed.ncbi.nlm.nih.gov/12807388

Use of Azathioprine for Non-Thymoma Myasthenia and Risk of Cancer: A Nationwide Case-Control Study in Denmark

Autor: David Gaist, Søren Friis, Emil Greve Pedersen, P. E. H. Jensen, Jesper Hallas, Anton Pottegård, Klaus Hansen

Publikováno v: ResearcherID
Pedersen, E G, Pottegård, A, Hallas, J, Friis, S, Hansen, K, Jensen, PEH & Gaist, D 2013, ' Use of azathioprine for non-thymoma myasthenia and risk of cancer : A nationwide case-control study in Denmark ', American Academy of Neurology (AAN) 65th Annual Meeting, San Diego, United States, 16/03/2013-23/03/2013 .
Pedersen, E G, Pottegård, A, Hallas, J, Friis, S, Hansen, K, Jensen, P E H & Gaist, D 2013, ' Use of azathioprine for non-thymoma myasthenia and risk of cancer : a nationwide case-control study in Denmark ', European Journal of Neurology, vol. 20, no. 6, pp. 942-948 . https://doi.org/10.1111/ene.12108

BACKGROUND AND PURPOSE: To evaluate the association between the use of azathioprine and risk of cancer in patients with non-thymoma myasthenia gravis (MG) in a nationwide setting. METHODS: Case-control study based on population-based registries. Case

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0e7265fc660977d0e21afbdbdd6b8828
http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcAuth=ORCID&SrcApp=OrcidOrg&DestLinkType=FullRecord&DestApp=WOS_CPL&KeyUT=WOS:000332068601255&KeyUID=WOS:000332068601255